Literature DB >> 31276627

circ-NOTCH1 acts as a sponge of miR-637 and affects the expression of its target gene Apelin to regulate gastric cancer cell growth.

Encui Guan1,1, Xiaoguang Xu1,1, Fangxi Xue1,1.   

Abstract

Gastric cancer (GC) is a major cause of cancer-related deaths worldwide, and has a low survival rate, low cure rate, high recurrence rate, and poor prognosis. Recent studies have indicated that circular RNAs (circRNAs) have important functions in the occurrence and progression of GC. Studies on circ-NOTCH1, which was shown to be highly expressed in GC, have indicated that miR-637 binds to circ-NOTCH1 at multiple sites, and a dual-luciferase reporter gene assay further confirmed that miR-637 indeed targeted circ-NOTCH1 and Apelin. Circ-NOTCH1 and Apelin are highly expressed in GC cells and tissues, whereas the expression of miR-637 is reduced. Circ-NOTCH1 and miR-637 do not regulate each other's expression levels, but circ-NOTCH1significantly upregulates the expression of the miR-637 target gene Apelin, whereas miR-637 inhibites the expression of Apelin. Examination of GC cells showed that circ-NOTCH1 enhances cell proliferation and invasiveness, and reduces cell apoptosis; these effects were reversed by miR-637, which could terminate the above effects of circ-NOTCH1. When co-transfected with the circ-NOTCH1 overexpression plasmid and Apelin siRNAs, there were no obvious changes to the levels of cell proliferation, apoptosis, or invasiveness. Therefore, in GC cells, circ-NOTCH1 inhibits the transcriptional activity of miR-637, thereby upregulating the expression of its target gene Apelin and regulating cell proliferation, apoptosis, and invasiveness. This finding provides more experimental evidence for the function of circRNA in GC.

Entities:  

Keywords:  ARNcirc; Apelin; apeline; cancer gastrique; circRNA; gastric cancer; miR-637

Mesh:

Substances:

Year:  2019        PMID: 31276627     DOI: 10.1139/bcb-2019-0079

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

Review 1.  Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.

Authors:  Xueping Tao; Yongfu Shao; Jianing Yan; Liyang Yang; Qihua Ye; Qingling Wang; Rongdan Lu; Junming Guo
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

2.  Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment.

Authors:  Xiuhua Liu; Liang Gao; Shaoxin Shi; Yun Yang
Journal:  Int J Gen Med       Date:  2021-01-22

Review 3.  Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer.

Authors:  Longfei Liu; Xiaoping Yi; Can Lu; Yong Wang; Qiao Xiao; Liang Zhang; Yingxian Pang; Xiao Guan
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

Review 4.  Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.

Authors:  Jinze Shen; Chenhao Liang; Xinming Su; Qurui Wang; Yufei Ke; Jie Fang; Dayong Zhang; Shiwei Duan
Journal:  Biomark Res       Date:  2022-09-30

Review 5.  Biological Roles and Mechanisms of Circular RNA in Human Cancers.

Authors:  Qing Tang; Swei Sunny Hann
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

6.  LncRNAs Predicted to Interfere With the Gene Regulation Activity of miR-637 and miR-196a-5p in GBM.

Authors:  Jingfang Zheng; Zhiying Su; Yang Kong; Qingping Lin; Hongli Liu; Yanlong Wang; Jian Wang
Journal:  Front Oncol       Date:  2020-03-09       Impact factor: 6.244

Review 7.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

8.  Circular RNA SOX5 promotes the proliferation and inhibits the apoptosis of the hepatocellular carcinoma cells by targeting miR-502-5p/synoviolin 1 axis.

Authors:  Yu Cai; Yuanyuan Jia
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.